Trials / Terminated
TerminatedNCT00450905
Pain Relief Investigation of Neuromodulation Therapy in an Adult Fibromyalgia Population
Randomized Evaluation of a Low-Frequency Investigational Device Employing Neuromodulation Therapy in Patients With Fibromyalgia
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Fralex Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is being performed to determine the safety and efficacy of Fralex Neuromodulation Therapy (F-NMT), delivered by the Fralex PRIMA device, in reducing chronic musculoskeletal pain associated with Fibromyalgia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PRIMA Device |
Timeline
- Start date
- 2007-03-01
- Completion
- 2008-12-01
- First posted
- 2007-03-22
- Last updated
- 2008-10-06
Locations
21 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00450905. Inclusion in this directory is not an endorsement.